Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and potential druggable targets from the ubiquitin sign...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0a0473fc75243f2b229229426d6900d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d0a0473fc75243f2b229229426d6900d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d0a0473fc75243f2b229229426d6900d2021-12-02T15:37:20ZProteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas10.1038/s41467-020-15955-w2041-1723https://doaj.org/article/d0a0473fc75243f2b229229426d6900d2020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15955-whttps://doaj.org/toc/2041-1723Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and potential druggable targets from the ubiquitin signaling machinery for treating human PTCs.Aswini KrishnanJean BertheletEmilie RenaudSebastian RosigkeitUte DistlerEric StawiskiJing WangZora ModrusanMarc FiedlerMariann BienzStefan TenzerArno SchadWilfried RothBernd ThiedeSomasekar SeshagiriThomas J. MusholtKrishnaraj RajalingamNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-16 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Aswini Krishnan Jean Berthelet Emilie Renaud Sebastian Rosigkeit Ute Distler Eric Stawiski Jing Wang Zora Modrusan Marc Fiedler Mariann Bienz Stefan Tenzer Arno Schad Wilfried Roth Bernd Thiede Somasekar Seshagiri Thomas J. Musholt Krishnaraj Rajalingam Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas |
description |
Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and potential druggable targets from the ubiquitin signaling machinery for treating human PTCs. |
format |
article |
author |
Aswini Krishnan Jean Berthelet Emilie Renaud Sebastian Rosigkeit Ute Distler Eric Stawiski Jing Wang Zora Modrusan Marc Fiedler Mariann Bienz Stefan Tenzer Arno Schad Wilfried Roth Bernd Thiede Somasekar Seshagiri Thomas J. Musholt Krishnaraj Rajalingam |
author_facet |
Aswini Krishnan Jean Berthelet Emilie Renaud Sebastian Rosigkeit Ute Distler Eric Stawiski Jing Wang Zora Modrusan Marc Fiedler Mariann Bienz Stefan Tenzer Arno Schad Wilfried Roth Bernd Thiede Somasekar Seshagiri Thomas J. Musholt Krishnaraj Rajalingam |
author_sort |
Aswini Krishnan |
title |
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas |
title_short |
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas |
title_full |
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas |
title_fullStr |
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas |
title_full_unstemmed |
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas |
title_sort |
proteogenomics analysis unveils a tfg-ret gene fusion and druggable targets in papillary thyroid carcinomas |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/d0a0473fc75243f2b229229426d6900d |
work_keys_str_mv |
AT aswinikrishnan proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT jeanberthelet proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT emilierenaud proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT sebastianrosigkeit proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT utedistler proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT ericstawiski proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT jingwang proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT zoramodrusan proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT marcfiedler proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT mariannbienz proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT stefantenzer proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT arnoschad proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT wilfriedroth proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT berndthiede proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT somasekarseshagiri proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT thomasjmusholt proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas AT krishnarajrajalingam proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas |
_version_ |
1718386201286672384 |